Alteration of fibroblast phenotype by asbestos-induced autoantibodies

References

• Baroni, S. S., Santillo, M., Bevilacqua, F., Luchetti, M., Spadoni, T., Mancini, M., Fraticelli, P., Sambo, P., Funaro, A., Kazlauskas, A., Avvedimento, E. V., and Gabrielli, A. 2006. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med. 354:2667–2676.
   PubMed Web of Science ®Google Scholar
• Chizzolini, C., Raschi, E., Rezzonico, R., Testoni, C., Mallone, R., Gabrielli, A., Facchini, A., Del Papa, N., Borghi, M. O., Dayer, J. M., and Meroni, P. L. 2002. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis. Arthritis Rheum. 46:1602–1613.
   PubMed Web of Science ®Google Scholar
• Conrad, K., Tan, E. M., Humbel, R. L., and Shoenfeld, Y. 1997. Autoantibodies - diagnostic, pathogenic and prognostic relevance. Clin Exp Rheumatol. 15:457–465.
   PubMed Web of Science ®Google Scholar
• Cooper, G. S., Miller, F. W., and Germolec, D. R. 2002. Occupational exposures and autoimmune diseases. Int Immunopharmacol. 2:303–313.
   PubMed Web of Science ®Google Scholar
• Davis, G. S., Leslie, K. O., and Hemenway, D. R. 1998. Silicosis in mice: effects of dose, time, and genetic strain. J Environ Pathol Toxicol Oncol. 17:81–97.
   PubMedGoogle Scholar
• Del Papa, N., Conforti, G., Gambini, D., La Rosa, L., Tincani, A., D’Cruz, D., Khamashta, M., Hughes, G. R., Balestrieri, G., and Meroni, P. L. 1994. Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis. Clin Immunol Immunopathol. 70:211–216.
   PubMedGoogle Scholar
• Fineschi, S., Cozzi, F., Burger, D., Dayer, J. M., Meroni, P. L., and Chizzolini, C. 2007. Anti-fibroblast antibodies detected by cell-based ELISA in systemic sclerosis enhance the collagenolytic activity and matrix metalloproteinase-1 production in dermal fibroblasts. Rheumatology (Oxford) 46:1779–1785.
   PubMed Web of Science ®Google Scholar
• Fineschi, S., Goffin, L., Rezzonico, R., Cozzi, F., Dayer, J. M., Meroni, P. L., and Chizzolini, C. 2008. Antifibroblast antibodies in systemic sclerosis induce fibroblasts to produce profibrotic chemokines, with partial exploitation of toll-like receptor 4. Arthritis Rheum. 58:3913–3923.
   PubMed Web of Science ®Google Scholar
• Hamilton, R. F., Iyer, L. L., and Holian, A. 1996. Asbestos induces apoptosis in human alveolar macrophages. Am J Physiol. 271:L813–L819.
   PubMed Web of Science ®Google Scholar
• Haustein, U. F., and Anderegg, U. 1998. Silica induced scleroderma - clinical and experimental aspects. J Rheumatol. 25:1917–1926.
   PubMed Web of Science ®Google Scholar
• Hénault, J., Tremblay, M., Clément, I., Raymond, Y., and Senécal, J. L. 2004. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis. Arthritis Rheum. 50:3265–3274.
   PubMedGoogle Scholar
• Hénault, J., Robitaille, G., Senécal, J. L., and Raymond, Y. 2006. DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients. Arthritis Rheum. 54:963–973.
   PubMed Web of Science ®Google Scholar
• Holian, A., Uthman, M. O., Goltsova, T., Brown, S. D., and Hamilton, R. F., Jr.. 1997. Asbestos and silica-induced changes in human alveolar macrophage phenotype. Environ Health Perspect. 105 Suppl 5:1139–1142.
   PubMed Web of Science ®Google Scholar
• Hudson, C. A., Cao, L., Kasten-Jolly, J., Kirkwood, J. N., and Lawrence, D. A. 2003. Susceptibility of lupus-prone NZM mouse strains to lead exacerbation of systemic lupus erythematosus symptoms. J Toxicol Environ Health Part A. 66:895–918.
   PubMed Web of Science ®Google Scholar
• Ihn, H., Sato, S., Fujimoto, M., Igarashi, A., Yazawa, N., Kubo, M., Kikuchi, K., Takehara, K., and Tamaki, K. 2000. Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis. Clin Exp Immunol. 119:203–209.
   PubMed Web of Science ®Google Scholar
• Jelaska, A., and Korn, J. H. 2000. Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis. Arthritis Rheum. 43:2230–2239.
   PubMed Web of Science ®Google Scholar
• Jindal, S. K., and Agarwal, R. 2005. Autoimmunity and interstitial lung disease. Curr Opin Pulm Med. 11:438–446.
   PubMed Web of Science ®Google Scholar
• Kadono, T., Kikuchi, K., Ihn, H., Takehara, K., and Tamaki, K. 1998. Increased production of interleukin 6 and interleukin 8 in scleroderma fibroblasts. J Rheumatol. 25:296–301.
   PubMed Web of Science ®Google Scholar
• Kaarteenaho-Wiik, R., Lakari, E., Soini, Y., Pöllänen, R., Kinnula, V. L., Pääkkö, P. 2000. Tenascin expression and distribution in pleural inflammatory and fibrotic diseases. J Histochem Cytochem. 48:1257–1268.
   Google Scholar
• Kawaguchi, Y. 1994. IL-1 alpha gene expression and protein production by fibroblasts from patients with systemic sclerosis. Clin Exp Immunol. 97:445–450.
   PubMed Web of Science ®Google Scholar
• Kirk, T. Z., Mark, M. E., Chua, C. C., Chua, B. H., and Mayes, M. D. 1995. Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1. J Biol Chem. 270:3423–3428.
   PubMed Web of Science ®Google Scholar
• Lasky, J. A., Tonthat, B., Liu, J. Y., Friedman, M., and Brody, A. R. 1998. Up-regulation of the PDGFα receptor precedes asbestos-induced lung fibrosis in rats. Am J Respir Crit Care Med. 157:1652–1657.
   PubMed Web of Science ®Google Scholar
• Mariani, T. J., Roby, J. D., Mecham, R. P., Parks, W. C., Crouch, E., and Pierce, R. A. 1996. Localization of type I pro-collagen gene expression in silica-induced granulomatous lung disease and implication of transforming growth factor-β as a mediator of fibrosis. Am J Pathol. 148:151–164.
   PubMed Web of Science ®Google Scholar
• Meeker, G., Bern, A., Brownfield, I., Lowers, H., Sutley, S., Hoefen, T., and Vance, J. 2003. The Composition and morphology of amphiboles from the Rainy Creek Complex, near Libby, Montana. Am Mineral. 88:1955–1969.
   Web of Science ®Google Scholar
• Nahm, D. H., Lee, Y. E., Yim, E. J., Park, H. S., Yim, H., Kang, Y., and Kim, J. K. 2002. Identification of cytokeratin 18 as a bronchial epithelial autoantigen associated with non-allergic asthma. Am J Respir Crit Care Med. 165:1536–1539.
   PubMed Web of Science ®Google Scholar
• Nigam, S. K., Suthar, A. M., Patel, M. M., Karnik, A. B., Dave, S. K., Kashyap, S. K., and Venkaiah, K. 1993. Humoral immunological profile of workers exposed to asbestos in asbestos mines. Indian J Med Res. 98:274–277.
   PubMed Web of Science ®Google Scholar
• Perdue, T. D., and Brody, A. R. 1994. Distribution of transforming growth factor-β1, fibronectin, and smooth muscle actin in asbestos-induced pulmonary fibrosis in rats. J Histochem Cytochem. 42:1061–1070.
   PubMed Web of Science ®Google Scholar
• Perkins, R. C., Scheule, R. K., Hamilton, R., Gomes, G., Freidman, G., and Holian, A. 1993. Human alveolar macrophage cytokine release in response to in vitro and in vivo asbestos exposure. Exp Lung Res. 19:55–65.
   PubMed Web of Science ®Google Scholar
• Pfau, J. C., Sentissi, J. J., Weller, G., and Putnam, E. A. 2005. Assessment of autoimmune responses associated with asbestos exposure in Libby, MT, USA. Environ Health Perspect. 113:25–30.
   PubMed Web of Science ®Google Scholar
• Pfau, J. C., Sentissi, J. J., Li, S., Calderon-Garciduenas, L., Brown, J. M., and Blake, D. J. 2008. Asbestos-induced autoimmunity in C57BL/6 mice. J Immunotoxicol. 5:129–137.
   PubMed Web of Science ®Google Scholar
• Prakash, U. B. 1998. Respiratory complications in mixed connective tissue disease. Clin Chest Med. 19:733–46, ix.
   PubMed Web of Science ®Google Scholar
• Putnam, E. A., Smartt, A., Groves, A., Schwanke, C., Brezinski, M., and Pershouse, M. A. 2008. Gene expression changes after exposure to six-mix in a mouse model. J Immunotoxicol. 5:139–144.
   PubMed Web of Science ®Google Scholar
• Rahimi, R. A., and Leof, E. B. 2007. TGFβ signaling: A tale of two responses. J Cell Biochem. 102:593–608.
   PubMed Web of Science ®Google Scholar
• Renaudineau, Y., Dugue, C., Dueymes, M., and Youinou, P. 2002. Anti-endothelial cell antibodies in systemic lupus erythematosus. Autoimmun Rev. 1:365–372.
   PubMedGoogle Scholar
• Revelen, R., Bordron, A., Dueymes, M., Youinou, P., and Arvieux, J. 2000. False positivity in a cyto-ELISA for anti-endothelial cell antibodies caused by heterophile antibodies to bovine serum proteins. Clin Chem. 46:273–278.
   PubMed Web of Science ®Google Scholar
• Revelen, R., D’Arbonneau, F., Guillevin, L., Bordron, A., Youinou, P., and Dueymes, M. 2002. Comparison of cell-ELISA, flow cytometry and Western blotting for the detection of anti-endothelial cell antibodies. Clin Exp Rheumatol. 20:19–26.
   PubMed Web of Science ®Google Scholar
• Ronda, N., Gatti, R., Giacosa, R., Raschi, E., Testoni, C., Meroni, P. L., Buzio, C., and Orlandini, G. 2002. Antifibroblast antibodies from systemic sclerosis patients are internalized by fibroblasts via a caveolin-linked pathway. Arthritis Rheum. 46:1595–1601.
   PubMedGoogle Scholar
• Sappino, A. P., Masouyé, I., Saurat, J. H., and Gabbiani, G. 1990. Smooth muscle differentiation in scleroderma fibroblastic cells. Am J Pathol. 137:585–591.
   PubMed Web of Science ®Google Scholar
• Singh, S., and du Bois, R. 2001. Autoantibodies in cryptogenic fibrosing alveolitis. Respir Res. 2:61–63.
   PubMed Web of Science ®Google Scholar
• Tamura, M., Liang, D., Tokuyama, T., Yoneda, T., Kasuga, H., Narita, N., Sada, K., Miyazaki, R., and Okada, S. 1993. [Study on the relationship between appearance of autoantibodies and chest X-ray findings of asbestos plant employees]. Sangyo Igaku. 35:406–412.
   PubMedGoogle Scholar
• Tamura, M., Tokuyama, T., Kasuga, H., Yoneda, T., Miyazaki, R., and Narita, N. 1996. [Study on correlation between chest X-P course findings and change in antinuclear antibody in asbestos plant employees]. Sangyo Eiseigaku Zasshi. 38:138–141.
   PubMedGoogle Scholar
• Tan, F. K., Arnett, F. C., Antohi, S., Saito, S., Mirarchi, A., Spiera, H., Sasaki, T., Shoichi, O., Takeuchi, K., Pandey, J. P., Silver, R. M., LeRoy, C., Postlethwaite, A. E., and Bona, C. A. 1999. Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin-1, in patients with scleroderma and other connective tissue diseases. J Immunol. 163:1066–1072.
   PubMed Web of Science ®Google Scholar
• Turner-Warwick, M., and Parkes, W. R. 1970. Circulating rheumatoid and antinuclear factors in asbestos workers. Br Med J. 3:492–495.
   PubMed Web of Science ®Google Scholar
• Warshamana, G. S., Pociask, D. A., Sime, P., Schwartz, D. A., and Brody, A. R. 2002. Susceptibility to asbestos-induced and transforming growth factor-β1-induced fibroproliferative lung disease in two strains of mice. Am J Respir Cell Mol Biol. 27:705–713.
   PubMed Web of Science ®Google Scholar
• Webber, J. S., Blake, D. J., Ward, T. J., and Pfau, J. C. 2008. Separation and characterization of respirable amphibole fibers from Libby, Montana. Inhal Toxicol. 20:733–740.
   PubMed Web of Science ®Google Scholar
• Whitehouse, A. C. 2004. Asbestos-related pleural disease due to tremolite associated with progressive loss of lung function: serial observations in 123 miners, family members, and residents of Libby, Montana. Am J Ind Med. 46:219–225.
   PubMed Web of Science ®Google Scholar
• Yang, J. M., Hildebrandt, B., Luderschmidt, C., and Pollard, K. M. 2003. Human scleroderma sera contain autoantibodies to protein components specific to the U3 small nucleolar RNP complex. Arthritis Rheum. 48:210–217.
   PubMedGoogle Scholar
• Yang, Y., Fujita, J., Bandoh, S., Ohtsuki, Y., Yamadori, I., Yoshinouchi, T., and Ishida, T. 2002. Detection of anti-vimentin antibody in sera of patients with idiopathic pulmonary fibrosis and non-specific interstitial pneumonia. Clin Exp Immunol. 128:169–174.
   PubMed Web of Science ®Google Scholar
• Youinou, P., Le Dantec, C., Bendaoud, B., Renaudineau, Y., Pers, J. O., and Jamin, C. 2006. Endothelium, a target for immune-mediated assault in connective tissue disease. Autoimmun Rev. 5:222–228.
   PubMed Web of Science ®Google Scholar